|
Mar 12
|
Rakovina's AI-driven Anti-Cancer Compounds in Pre-clinical Testing
|
|
Mar 12
|
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
|
|
Jul 27
|
Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
|
|
Jun 20
|
Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting
|